Peng Zhou

FDA investigator

Appears on 15 documents from 2019 to 2025, mostly at sites in Illinois. Most often cites responsibilities of quality control unit (21 CFR 211.22).

15
Documents on file
2.6
Observations per 483
2019
First seen
2025
Most recent

What they cite most

From 43 observations

Activity by year

2019: 2, 2020: 2, 2021: 1, 2022: 2, 2023: 3, 2024: 3, 2025: 2

Where

Illinois 8 · Iowa 2 · California 1 · Maryland 1 · Michigan 1 · Wisconsin 1

Is Peng Zhou coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

15 documents, newest first
FirmOpen
483 Baxalta US Inc.Nov 26, 2025 · Round Lake, Illinois
483 CoreRX Inc.Mar 20, 2025
483 Form FDA 483 Kite Pharma November 2024Nov 1, 2024 · Frederi ck, Maryland
483 Grifols Biologicals LLCMay 3, 2024 · Los Angeles, California
483 Rna Pharma, LLCMar 8, 2024 · Blue Island, Illinois
483 Athea Laboratories IncDec 20, 2023 · Milwaukee, Wisconsin
483 Vee Pak, LLC dba Voyant BeautyDec 11, 2023 · Countryside, Illinois

About this profile

What does Peng Zhou inspect?

Peng Zhou appears on 15 documents on file covering 14 sites, mostly in Illinois.

What do they cite most often?

21 CFR 211.22 (responsibilities of quality control unit), followed by 21 CFR 211.42 and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Peng Zhou is dated Nov 26, 2025.